Add to watchlist

Ocular Therapeutix, Inc. (OCUL)

Last Price$8.511.2%

Market Cap$1,347.5M

#OCUL Dividend Yield

#OCUL Dividend Per Share

#OCUL Dividend Payout Ratio

#Competing with OCUL Dividend

Overview

Ratings

Intrinsic Value

Valuation

Growth

Profitability

Health

Capital allocation

Momentum

Earnings

Dividends

Company name	Market Cap	Dividend Payout Ratio (LTM)	Cash Flow Payout Ratio (LTM)	DPS growth 1Y	DPS growth 3Y	DPS growth 10Y	Dividend Yield	Yield on Cost (1Y)	Yield on Cost (5Y)
Ocular Therapeutix, Inc.OCUL OCUL	$1,347.5M	0.0%	0.0%	N/A	N/A	(100.0%)	0.0%	0.0%	0.0%
Vertex Pharmaceuticals IncorporatedVRTX VRTX	$124.8B	0.0%	0.0%	N/A	(100.0%)	N/A	0.0%	0.0%	0.0%
Regeneron Pharmaceuticals, Inc.REGN REGN	$77.0B	0.0%	0.0%	N/A	N/A	(100.0%)	0.0%	0.0%	0.0%
argenx SEARGX ARGX	$34.4B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Alnylam Pharmaceuticals, Inc.ALNY ALNY	$30.7B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BioNTech SEBNTX BNTX	$24.0B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Royalty Pharma plcRPRX RPRX	$14.5B	28.3%	13.6%	8.3%	10.7%	(15.1%)	2.6%	2.8%	2.4%
United Therapeutics CorporationUTHR UTHR	$13.8B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BioMarin Pharmaceutical Inc.BMRN BMRN	$13.4B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Summit Therapeutics Inc.SMMT SMMT	$13.3B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BeiGene, Ltd.BGNE BGNE	$1,846.9M	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%